Search
for
Sort by
Research 91–120 of 777
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Spotlight in Plastic Surgery: October 2022
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Ruxolitinib for the treatment of severe alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- New drugs under investigation for the treatment of alopecias
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Treatment of severe alopecia areata with baricitinib
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Alopecia universalis successfully treated with tofacitinib
- Current and future pharmacotherapy for alopecia areata